Biotechnology and the Law
American Bar Association - Defending Liberty, Pursuing Justice ABA
View Cart & Check Out
ABA Web Store
                               
...the source you trust for practical legal information.
Sign In

View Cart & Check Out

Track Orders

Shipping Rates

Help

Administrative Law

Antitrust Law

Bankruptcy Law

Business Law

Career Development

Construction Law

Corporate Law

Criminal Law

Dispute Resolution

Elder Law

Environmental Law

Estate Planning

Evidence

Family Law

Financial Management

Franchise Law

Health Law

Insurance Law

Intellectual Property Law

International Law

Labor & Employment Law

Law Practice Management

Legal Technology

Litigation

Marketing

Mergers & Acquisitions

Professional Responsibility

Real Estate Law

Securities Law

Taxation

Tort Law

Advanced Search
Site Map

Biotechnology and the Law

Biotechnology and the Law
Product Code: 5450044
Editors: Hugh B. Wellons, Eileen Smith Ewing, Robert F. Copple, William N. Wofford, Erika King Lietzan
Publication Date: January 2007
ISBN: 978-1-59031-761-7
Page Count: 957
Trim Size: 7 x 10 Paperback
Sponsoring Entities: Section of Science & Technology Law
Topics: Science & Engineering Law, Technology Law
Format: Book - 5450044
Pricing: $189.95 (Regular)
$169.95 (Section of Science & Technology Law) ABA Members, Log in now to receive this discount!
Quantity:
 
Purchase 5-24 and save 10%
Purchase 25-49 and save 20%
Purchase 50-99 and save 30%
Purchase 100+ and save 40%
 
Related Products

Science for Lawyers

Science for Lawyers

Save 20% when you buy them together.

About the Book

Biotechnology and the Law is written to help lawyers faced with the challenge of identifying the legal issues and processes that must be faced by their clients in building, marketing, and protecting a biotech business. The contributors are experts in this specialized area and provide thorough, yet accessible, overviews of biotech subspecialties with an eye to practical application. A biotech legal practice involves specialized subject matter and regulatory schemes that, generally, are not part of the business lawyer's repertoire and which can present many hazards for the uninitiated. Because of the expansion in biotech practice beyond the traditional organizations and their representatives, this guide was written to help lawyers find their way through the biotech maze.

This book contains over 20 chapters by more than 20 leading experts in specialties such as patents, company formation, finance, federal regulation of research through funding, FDA regulation of biomedical research, approval of products for human use, privacy issues, litigation issues and more.

What Other People Are Saying

"Biotechnology and the Law is a well-written, well-edited book that will assist any lawyer who is involved with, or who expects to be involved with, a case concerning the biotechnology industry."

David William Becker, Jr.
The Colorado Lawyer

Additional Resources

The editors and authors of Biotechnology and the Law have distilled the book's 950 pages and 21 chapters into a fast- paced overview of key legal issues that affect a biotech company through its complex life cycle.

Biotechnology and the Law: A Primer, Part One (Audio CD Package)
In the first session, the panel will start with the fundamentals of corporate structure and other issues in starting up a biotech company. They will cover dos and don'ts of acquiring the key ingredients namely, intellectual property, staff, and financing. The first session concludes with a discussion of research, development and commercial collaborations.

Biotechnology and the Law: A Primer, Part Two (Audio CD Package)
In the second session, the panel provides an overview of the regulatory approval process, explaining how a scientific discovery becomes an approved pharmaceutical or biologic product. Patent counsel sketch out how patent prosecution and litigation unfold and impact the success or failure of a biotech company. Finally, the panel discusses which missteps can lead to litigation and strategies to help minimize and manage these risks. Although primarily focused on U.S. legal issues, the panelists will touch on select aspects of E.U. and other foreign laws that can dramatically affect a biotech company's prospects for success.

More Information

Preface PDF
About the Editors PDF
About the Contributors PDF
Table of Contents PDF


Get Adobe Reader